Michel Rivoire
Lyon, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 120 publications
Risk factors associated with urinary tract infection within 4 days of male rectal cancer surgery in the era of enhanced recovery after surgery (ERAS) programs.
Journal: Acta chirurgica Belgica
Published: June 05, 2026
Organ Preservation in Rectal Cancer Management: A Prospective GRECCAR Snapshot Study.
Journal: Diseases of the colon and rectum
Published: April 29, 2026
Corrigendum to "An alternative model for HEV infection in the HepaRG cell line" [J. Virol. Methods 340 (2026) 115307].
Journal: Journal of virological methods
Published: December 25, 2025
Contemporary neoadjuvant strategies for rectal cancer: The GRECCAR snapshot study.
Journal: Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland
Published: September 21, 2025
An alternative model for HEV infection in the HepaRG cell line.
Journal: Journal of virological methods
Published: August 01, 2025
Frizzled 7 drives amplification of cancer stem-cell subpopulations and the aggressiveness and poor differentiation of human hepatocellular carcinoma.
Journal: PloS one
Published: May 30, 2025
HBV-driven host chromatin accessibility changes affect liver metabolic pathways, iron homeostasis and promote a preneoplastic phenotype.
Journal: Journal of experimental & clinical cancer research : CR
Published: March 03, 2025
An Open-label, Randomized Study of Melphalan/Hepatic Delivery System Versus Best Alternative Care in Patients with Unresectable Metastatic Uveal Melanoma.
Journal: Annals of surgical oncology
Published: January 02, 2025
A novel in vitro system for simultaneous infections with hepatitis B, C, D and E viruses.
Journal: JHEP reports : innovation in hepatology
Published: November 20, 2024
Protocol for isolating CD163+ Kupffer cells from human liver resections.
Journal: STAR protocols
Published: July 19, 2024
Correction: Efficacy and Safety of the Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma: Results from an Open-Label, Single-Arm, Multicenter Phase 3 Study.
Journal: Annals of surgical oncology
Published: July 18, 2024
Last Updated: 09/26/2026